Пациентите, лекувани с Trudexa, получиха на 12- та седмица статистически значимо пр
Trudexa treated patients had significantly greater improvement at Week 12 which was maintained through Week 24 in both the SF36 and Ankylosing Spondylitis Quality of Life Questionnaire